ACT.DE
AlzChem Group AG
Price:  
122 
EUR
Volume:  
25,038
Germany | Chemicals

ACT.DE WACC - Weighted Average Cost of Capital

The WACC of AlzChem Group AG (ACT.DE) is 7.5%.

The Cost of Equity of AlzChem Group AG (ACT.DE) is 7.7%.
The Cost of Debt of AlzChem Group AG (ACT.DE) is 4.25%.

RangeSelected
Cost of equity6.1% - 9.3%7.7%
Tax rate26.8% - 27.2%27%
Cost of debt4.0% - 4.5%4.25%
WACC5.9% - 9.1%7.5%
WACC

ACT.DE WACC calculation

CategoryLowHigh
Long-term bond rate2.8%3.3%
Equity market risk premium5.1%6.1%
Adjusted beta0.640.91
Additional risk adjustments0.0%0.5%
Cost of equity6.1%9.3%
Tax rate26.8%27.2%
Debt/Equity ratio
0.040.04
Cost of debt4.0%4.5%
After-tax WACC5.9%9.1%
Selected WACC7.5%

ACT.DE's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for ACT.DE:

cost_of_equity (7.70%) = risk_free_rate (3.05%) + equity_risk_premium (5.60%) * adjusted_beta (0.64) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.